Table of Contents

• 1. Website
• 2. Name of journal
• 3. Peer review process
• 4. Ownership and management
• 5. Governing body
• 6. Editorial team and contact information
• 7. Copyright and licensing
• 8. Author fees
• 9. Process to manage the research and publication misconduct
• 10. Publication ethics
• 11. Publishing schedule
• 12. Access
• 13. Archiving policy
• 14. Revenue sources
• 15. Advertising policy
• 16. Direct marketing

1. Website

• i. The URL address of official journal web site is https://e-dmj.org.

• ii. 'Aims & Scope' statement: The aims of the Diabetes & Metabolism Journal are to contribute to the cure of and education about diabetes mellitus, and the advancement of diabetology through the sharing of scientific information on the latest developments in diabetology among members of the Korean Diabetes Association and other international societies.
• The Journal publishes articles on basic and clinical studies, focusing on areas such as metabolism, epidemiology, pathogenesis, complications, and treatments relevant to diabetes mellitus. It also publishes articles covering obesity and cardiovascular disease. Articles on translational research and timely issues including ubiquitous care or new technology in the management of diabetes and metabolic disorders are welcome. In addition, genome research, meta-analysis, and randomized controlled studies are welcome for publication.
• The editorial board invites articles from international research or clinical study groups. Publication is determined by the editors and peer reviewers, who are experts in their specific fields of diabetology.
• iii. Readership: It is primarily for endocrinologists who seek tailored information about diabetes and metabolism, but its readership can be expanded to other positions; Researchers have access to recent clinical diabetes and metabolism research topics and detailed research methods; Clinicians in the field have access to new information and recent diabetes care developments for their patients; Medical teachers are able to access and adopt a variety of medical education data; Allied health professionals, including nurses, have access to recent information concerning the care of subjects with diabetes and metabolic diseases; Medical health students can learn about recent trends in the field and read about interesting cases; Policymakers are able to reflect on the article results and apply them in nationwide healthcare policies for subjects with diabetes and metabolic diseases; The public, especially subjects with diabetes and metabolic diseases, are able to read about the advancements in their diseases, increasing their knowledge and inspiring confidence in the clinicians and researchers' devotion.
• iv. Authorship criteria: http://www.e-dmj.org/authors/authors.php
• According to the ICMJE guidelines, the authors of the paper must have met all of the following criteria:
  • 1) Contributed to the creation of the basic concept or design of the study, as well as the analysis or the interpretation of the data.
  • 2) Written the manuscript, edited a major portion, or made a significant contribution that improved the contents of the manuscript.
  • 3) Agreed to the contents of the final manuscript.
  • 4) Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
• The author list should include all appropriate researchers and no others, who provides credit for a researcher’s contributions to a study and carries accountability.
• v. Duplicate submission and redundant publication: http://www.e-dmj.org/authors/ethics.php
• The submitted manuscripts must be original. The manuscript may not be considered for publication in another magazine or journal. Additionally, no part of the manuscript may be published elsewhere without permission from the editorial board. In the event that a publishing violation has occurred, the journal will be notified, the offenders may be penalized, and the institutions affiliated with the authors will be notified.
• vi. pISSN: 2233-6079 eISSN; 2233-6087

2. Name of journal

• The official journal title is Diabetes & Metabolism Journal. Abbreviated title is Diabetes Metab J.

3. Peer review process

http://www.e-dmj.org/authors/authors.php

• Submitted manuscripts are first reviewed by manuscript editors. Unless they meet submission criteria, they will be sent back to the authors for a resubmission after corrections have been made. Then, the priority of the submitted manuscript to dmj will be initially assessed by the associate editors. Papers deemed suitable are then typically sent to expert reviewers to assess the scientific quality of the paper. This journal uses double-blind review throughout the review process. If necessary, the associate editor may consult statisticians during the review process. Based on the review results, the associate editor decides whether manuscripts will be able to proceed to revision or be rejected.

4. Ownership and management

http://www.diabetes.or.kr/english/

• Information about the ownership: This journal is owned by the publisher, the Korean Diabetes Association http://www.diabetes.or.kr
• Management team of a journal (http://e-dmj.org/about/management.php)

• Management team of a journal

  • Journal Manager

     Kyung Mook Choi     Korea University, Seoul, Korea
  

  • Manager of the Review Process

     Seung-Hyun Ko     The Catholic University of Korea, Seoul, Korea
     Hye Jin Yoo     Korea University, Seoul, Korea
     Dae Jung Kim     Ajou University, Suwon, Korea
     Sung Hee Choi     Seoul National University, Seoul, Korea
     Hye Soon Kim     Keimyung University, Daegu, Korea
     Sang Yong Kim     Chosun University, Gwangju, Korea
     Ji A Seo     Korea University, Ansan, Korea
     Hyon-Seung Yi     Chungnam National University, Daejeon, Korea
     Soo Heon Kwak     Seoul National University, Seoul, Korea
     Sang Youl Rhee     Kyung Hee University, Seoul, Korea
     Seung Hwan Lee     The Catholic University of Korea, Seoul, Korea
     Yongho Lee     Yonsei University, Seoul, Korea
     Hye Jin Lee     Ewha Womans University, Seoul, Korea
     Chang Hee Jung     University of Ulsan, Seoul, Korea
     Eun-Hee Cho     Kangwon University, Chuncheon, Korea
     Sang-Man Jin     Sungkyunkwan University, Seoul, Korea
     Jun Sung Moon     Yeungnam University, Daegu, Korea
     Mi-kyung Kim     Inje University, Busan, Korea
     Sung Hoon Yu     Hanyang University, Guri, Korea
  

  • Statistics Editors

     Hyeon Chang Kim     Yonsei University
     Seonwoo Kim     Samsung Biomedical Research Institute
     Mi Ra Park     Eulji University
     Hong-Yup Ahn     Dongguk University
     Hyeon Woo Yim     The Catholic University of Korea, Korea
     Yong Moon Park     National Institutes of Health, USA
     Su Jin Jeong     Kyung Hee University Medical Center, Seoul, Korea
     Yong-Gyu Park     The Catholic University of Korea, Seoul, Korea

  • Manuscript Editor

     Young Ji Choi     Infolumi, Korea
  

  • Layout editor

     Mee Kyoung Kim     Academya, Korea
  

  • Website and JATS XML File Producers

      Min Young Choi      M2PI, Korea

5. Governing body

• The governing body is the journal's editorial board.

6. Editorial team and contact information

http://e-dmj.org/about/editorial.php

• Editorial office contact information
  Diabetes & Metabolism Journal Editorial Office
• 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea.
• Tel: +82-2-714-9064 / Fax: +82-2-714-9084
• E-mail: diabetes@kams.or.kr

7. Copyright and Licensing

http://e-dmj.org/about/open_access.php

• i. Copyright policy: All published papers become the permanent property of the Korean Diabetes Association. Copyrights of all published materials are owned by the Korean Diabetes Association. Permission must be obtained from the Korean Diabetes Association for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
• ii. Licensing information: This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).
• iii. Deposit policy: According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.

8. Author fees

http://www.e-dmj.org/authors/processing_charge.php

• An article processing charge of $600 will be applicable for arti­cles accepted for publication in the Diabetes & Metabolism Journal. Submission of the article to the journal can be completed once the payment method has been agreed. Any applicable article processing charge must be paid prior to publication.
  NOTE: Effective from January 1, 2023, an article processing charge of $600 will be applicable for non-industry sponsored articles and $1000 for industry sponsored articles accepted for publication in the Diabetes & Metabolism Journal.
  The article processing charges are waived for articles from low income countries.
  Low income countries: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
  Invited review articles are exempt from article charges.

9. Process to manage the research and publication misconduct

http://www.e-dmj.org/authors/ethics.php

• The dmj is a member of Cross-Check’s plagiarism detection initiative and takes seriously all cases of publication misconduct. When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). All reviewers have a responsibility to report to the Editor about any suspected issues with the manuscript. If the investigation proves scientific misconduct, publish a retraction of the article. If warranted, the authors should be invited to prepare the retraction, which should be submitted with an assignment of copyright statement that has been signed by all authors. If the paper has not been published then the Editor can always reject the paper. Instances of misconduct in the publication process will be shared with the editorial board of the dmj journal. The Editor may wish to impose sanctions, notify editors of other biomedical journals, and depending on the severity of the allegation, notify the author’s institution. The dmj will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when the misconduct is founded.

10. Publication Ethics

http://www.e-dmj.org/authors/ethics.php

• i. Journal policies on authorship and contributorship
  According to the ICMJE guidelines, the authors of the paper must have met all of the following criteria:
  • 1) Contributed to the creation of the basic concept or design of the study, as well as the analysis or the interpretation of the data.
  • 2) Written the manuscript, edited a major portion, or made a significant contribution that improved the contents of the manuscript.
  • 3) Agreed to the contents of the final manuscript.
  • 4) Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  The author list should include all appropriate researchers and no others, who provides credit for a researcher’s contributions to a study and carries accountability.
• ii. How the journal will handle complaints and appeals
  The dmj adheres to COPE guidelines (https://publicationethics.org/appeals) regarding appeals to editorial decisions and complaints.
• iii. Journal policies on conflicts of interest/competing interests
  The dmj requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘Conflict of Interest’ section at the end of the manuscript listing all competing interests (financial and non-financial). Financial relationships such as employment, consultancies, stock ownership, honoraria, and paid expert testimony are the most easily identifiable conflicts of interest. Conflicts can occur for other reasons as well, such as personal relationships, academic competition, and intellectual passion (http://www.icmje.org/conflicts-of-interest/). Where authors have no competing interests, the statement should read “The author(s) declare(s) that they have no competing interests”. If the study was sponsored by a third party, authors should describe the role of the study sponsor in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state.
• iv. Journal policies on data sharing and reproducibility
  The dmj recommends that all submitted manuscripts that report the results of clinical trials should adhere to the “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). (http://www.icmje.org/icmje-recommendations.pdf)
• v. Journal's policy on ethical oversight
  The dmj is a member of Cross-Check’s plagiarism detection initiative and takes seriously all cases of publication misconduct. When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). All reviewers have a responsibility to report to the Editor about any suspected issues with the manuscript. If the investigation proves scientific misconduct, publish a retraction of the article. If warranted, the authors should be invited to prepare the retraction, which should be submitted with an assignment of copyright statement that has been signed by all authors. If the paper has not been published then the Editor can always reject the paper. Instances of misconduct in the publication process will be shared with the editorial board of the dmj journal. The Editor may wish to impose sanctions, notify editors of other biomedical journals, and depending on the severity of the allegation, notify the author’s institution. dmj will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when the misconduct is founded.
• vi. Journal's policy on intellectual property
  All published papers become the permanent property of the Korean Diabetes Association. Copyrights of all published materials are owned by the Korean Diabetes Association.
• vii. Journal's options for postpublication discussions and corrections
  The postpublication discussion is available through letter to the editor. If any readers have a concern on any articles published, they can submit letter to the editor on the articles. If there founds any errors or mistakes in the article, it can be corrected through errata, corrigenda, or retraction.

11. Publishing schedule

http://www.e-dmj.org/about/about.php

• It is to be published bimonthly.

12. Access

http://www.e-dmj.org/about/about.php

• This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

13. Archiving policy

• It is accessible without barrier from PubMed Central (https://pubmedcentral.gov), Korea Citation Index (https://kci.go.kr), or National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.

14. Revenue sources

• Revenue sources of journal were from the support of publisher (the Korean Diabetes Association), Korea Government's support through Korean Federation of Science and Technology Societies), and advertising rates.

15. Advertising policy

• It accepts advertisements on the following basis:
• Eligibility of the advertised products or services
  All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
  • - Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
  • - We reserve the right to decline or cancel any advertisement at any time.
  • - Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.
• Orders
  Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the editorial office. The acceptance of advertisement will be discussed by the editorial board and will be ultimately approved by the publisher.
• Advertisement fee
  This academic journal and the advertisement price follow in accordance with the KRPIA Fair Competition Code and Working Guideline: http://members.krpia.or.kr/bbs/bbs_view.asp?num=540&bd_gubun=02
• Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.
• Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
• Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.

16. Direct marketing

• Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.